[S-30] Symposium 30

[S-30-4] Phase II study of a protein aggregation inhibitor for polyglutamine disease

^○Tomohiko Ishihara¹, Yoshitomi Kanemitsu², Masayoshi Tada^1,3, Kensuke Ikenaka⁴, Yuji Takahashi⁵, Takanori Yokota⁶, Kinya Ishikawa⁷, Makito Hirano⁸, Yoshitaka Nagai⁸, Osamu Onodera¹ (1.Niigata University BRI, Japan, 2.Niigata University CTRC, 3.Niigata City General Hospital, 4.Osaka University, 5.National Center of Neurology and Psychiatry, 6.Tokyo Medical and Dental University, 7.Tokyo Medical and Dental University, 8.Kinki University)